Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3252 Target Snapshot

Beta-1 adrenergic receptor · SINGLE PROTEIN · Rattus norvegicus

378Compounds
80Assays
19Approved Drugs
319.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P18090. Use UniProt P18090 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P18090 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-1 adrenergic receptor as ChEMBL target CHEMBL3252, mapped to UniProt P18090. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-1 adrenergic receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3252
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P18090
Beta-1 adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-1 adrenergic receptor is the right protein anchor across sources, using UniProt P18090 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-1 adrenergic receptor
UniProt AccessionP18090
Component TypeProtein
Sequence Length466 aa

Beta-1 adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-1 adrenergic receptor, mapped to UniProt P18090. Sequence length is 466 aa.

Mapped IDP18090
Review nameBeta-1 adrenergic receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

19
Approved
Assay Mix

Activity Type Distribution

IC5023.0
KI229.0
EC5012.0
KD55.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL378501 10.4 Ki 0.03981 Preclinical
CHEMBL210309 10.2 Kd 0.0631 Preclinical
CHEMBL543955 9.56 Kd 0.2754 Preclinical
CHEMBL267375 9.3 Kd 0.5012 Preclinical
CHEMBL723 9.09 Ki 0.81 Approved
CHEMBL280822 8.9 Ki 1.259 Preclinical
CHEMBL542536 8.7 Kd 1.995 Preclinical
CHEMBL477466 8.7 Ki 2.0 Preclinical
CHEMBL27 8.62 Kd 2.399 Approved
CHEMBL423 8.53 Kd 2.951 Approved
Distribution

pChEMBL Value Distribution

22
5.0
26
5.5
26
6.0
21
6.5
24
7.0
17
7.5
16
8.0
13
8.5
2
9.0
5
9.5
pChEMBL
Approved Drugs

Approved Drugs

LEVOBETAXOLOL
CHEMBL1201274
Approved 2000
CARVEDILOL
CHEMBL723
Approved 1995
BETAXOLOL HYDROCHLORIDE
CHEMBL1691
Approved 1985
BETAXOLOL
CHEMBL423
Approved 1985
TIMOLOL
CHEMBL499
Approved 1978
METOPROLOL
CHEMBL13
Approved 1978
PROPRANOLOL
CHEMBL27
Approved 1967
ISOPROTERENOL
CHEMBL434
Approved 1956
NOREPINEPHRINE
CHEMBL1437
Approved 1950
Assay Landscape

Assay Landscape

80
Total Assays
140
Tested Compounds
2
Assay Types
Binding — 48 assays, 140 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 13 47 5.5
tissue-based format 12 30 6.4
single protein format 11 12 6.5
cell membrane format 10 51 5.3
cell-based format 2 0
Functional — 32 assays, 50 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 18 34 7.2
cell-based format 5 8 7.6
tissue-based format 5 8 7.2
organism-based format 4 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine